Considerable overlap has been identified in the risk factors, comorbidities and putative
pathophysiological mechanisms of Alzheimer disease and related dementias (ADRDs) and …

Since 2006, several longitudinal studies have assessed environmental or behavioural
factors that seem to modify the risk of develo** Parkinson's disease. Increased risk of …

Parkinson disease (PD) is the second most common age-related neurodegenerative
condition diagnosed in North America. We recently demonstrated, using multiple …

Abstract Background Type 2 diabetes (T2DM) and Parkinson's disease (PD) are prevalent
diseases that affect an aging population. Previous systematic reviews and meta‐analyses …

The gut microbiome comprises the collective genome of the trillions of microorganisms
residing in our gastrointestinal ecosystem. The interaction between the host and its gut …

There is growing evidence that patients with Type 2 diabetes have an increased risk of
develo** Parkinson's disease and share similar dysregulated pathways suggesting …

Background Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive form of
brain stimulation that positively regulates the motor and non-motor symptoms of Parkinson's …

Introduction: This review evaluates the novel strategy of treating Alzheimer's and Parkinson's
disease (AD and PD) withdrugs that initially have been developed to treat type 2 diabetes …

α-Synuclein misfolding and aggregation is a hallmark in Parkinson's disease and in several
other neurodegenerative diseases known as synucleinopathies. The toxic properties of α …

Parkinson's disease (PD) is the second most common age-associated neurodegenerative
disorder and is characterised by progressive loss of dopamine neurons in the substantia …